Latest News and Press Releases
Want to stay updated on the latest news?
-
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies...
-
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK, Friday August 27, 2021 – ImmunoBrain Checkpoint Inc....
-
BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Rendever, a virtual reality (VR) platform built to help seniors overcome social isolation through shared experiences, today announces that it has been...
-
New York, June 08, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease...
-
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Posit Science, the maker of BrainHQ computerized brain exercises, has been awarded a federal grant to measure the impact of BrainHQ training on the...
-
Pittsburgh, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic health and restoration in Alzheimer’s disease and other ...
-
PALO ALTO, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- People Power, Internet of Things (IoT) software company providing white-label IoT solutions for energy, security and care services, announces...
-
CAMDEN, N.J., June 10, 2015 (GLOBE NEWSWIRE) -- The Coriell Institute for Medical Research has won a five-year, $6.5M award from the National Institutes of Health (NIH) to advance research on aging,...